AIDP’s KoACT, a patented chelated compound of calcium and hydrolyzed collagen peptides that has been shown to increase both bone strength and bone mineral density in animal studies and in a recent human study to increase biomarkers of bone growth, has received GRAS (Generally Recognized As Safe) status.
AIBMR Life Sciences Inc. evaluated the safety assessment of KoACT and concluded its intended use as a food ingredient is produced in accordance with Good Manufacturing Practices. The AIBMR panel concluded that the addition levels per food serving are GRAS based upon scientific procedures and corroborated by an extensive history of safe use.
KoACT, with three U.S. patents, provides the bone support by combining calcium and collagen together as a patented nutritional ingredient. KoACT was found to increase bone strength nearly 10% over a simple mixture of calcium and collagen alone in an animal study performed at the Tokyo University of Agriculture and Technology. Suggested delivery forms for KoACT are tablets, capsules, soft-gels, and functional food applications.